Trials to watch: First cancer vaccine success could trigger a domino effect

Following the first successful Phase III trial of an mRNA cancer vaccine, interest in the modality has surged. Following the first successful Phase III trial of an mRNA cancer vaccine, interest in the modality has surged. Cancer vaccines have the potential to slow disease progression, but as a modality, it remains in the early stages. Credit: Giovanni Cancemi / Shutterstock.com Unlock FREE Access to Premium Content ​Discover exclusive forecasts, analyst insights, and in-depth clinical trials industry analysis across drug development, clinical research, and trial innovation. With a free Clinical Trials Arena profile, you can: Experience unmatched clarity with a single…

Source: Clinical Trials Arena